Cardiomyopathy Trial, Recruiting NCT04464655 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT04464655
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy volunteers:

  • You are over 18 years old and able to give informed consent
  • You do not have any known significant medical conditions that affect your heart or breathing

For patients:

  • You are over 18 years old and able to give informed consent
  • You have already been referred by your doctor for a cardiac MRI scan (CMR) as part of your normal care

Who may not be able to join:

For healthy volunteers:

  • You have a pacemaker, defibrillator, or any implanted device or foreign body in your body that is not safe for MRI scans
  • You have consumed any caffeinated drinks or foods (including cocoa or chocolate) in the 12 hours before the scan
  • You have regularly used nicotine products in the last 6 months

For patients:

  • You have a pacemaker, defibrillator, or any implanted device or foreign body in your body that is not safe for MRI scans
  • You have taken blood vessel-affecting medications (such as nitro-based medicines) in the 12 hours before the scan
  • You have consumed any caffeinated drinks or foods (including cocoa or chocolate) in the 12 hours before the scan
  • You have regularly used nicotine products in the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthias G Friedrich, MD, Research Institute of the McGill University Health Center

Phone: 514-934-1934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry
ClinicalTrials.gov
Start date
12 December 2019
Est. completion
30 November 2024

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Primary diagnosis comparison between SMART CMR and standard CMR; Main finding comparison between SMART CMR and standard CMR in patients with suspected coronary artery disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov